Serum albuterol levels in mechanically ventilated patients and healthy subjects after metered-dose inhaler administration.

1996 ◽  
Vol 154 (6) ◽  
pp. 1658-1663 ◽  
Author(s):  
A G Duarte ◽  
R Dhand ◽  
R Reid ◽  
J B Fink ◽  
P J Fahey ◽  
...  
CHEST Journal ◽  
1995 ◽  
Vol 107 (1) ◽  
pp. 210-213 ◽  
Author(s):  
Constantine A. Manthous ◽  
Wissam Chatila ◽  
Gregory A. Schmidt ◽  
Jesse B. Hall

1993 ◽  
Vol 148 (6_pt_1) ◽  
pp. 1567-1570 ◽  
Author(s):  
Constantine A. Manthous ◽  
Jesse B. Hall ◽  
Gregory A. Schmidt ◽  
Lawrence D. H. Wood

1996 ◽  
Vol 3 (5) ◽  
pp. 331-334 ◽  
Author(s):  
Yves Lacasse ◽  
Louis-Philippe Boulet ◽  
Noël Lampron

Aerosols have gained wide acceptance over the past 10 years for the treatment of obstructive diseases. However, much controversy still exists about their use and mode of administration in the setting of intensive care units for intubated patients. The current literature was reviewed addressing the following question: In intubated and mechanically ventilated patients with airway obstruction, should bronchodilator aerosols be delivered through a metered-dose inhaler (MDI) or a nebulizer in order to reduce complications associated with high airway resistance? Most often investigators have examined, in uncontrolled trials, the effect of bronchodilator aerosols administered either through MDIs or nebulizers in lung models, or in populations of patients with heterogeneous conditions. An extremely wide range of bronchodilator dosages has been studied. Clinical outcomes have consisted of either drug deposition or lung mechanical characteristics. Only three randomized controlled trials comparing the effects of bronchodilator aerosols delivered through a nebulizer to those delivered through an MDI have been published, without clearly demonstrating the superiority of one mode of administration over the other. There is a need for randomized controlled trials comparing the effect of bronchodilator aerosols delivered through nebulizer versus MDI on the incidence of ventilator-associated complications in mechanically ventilated patients with obstructive lung diseases.


1996 ◽  
Vol 24 (5) ◽  
pp. 870-874 ◽  
Author(s):  
Sandra S. Garner ◽  
Donald B. Wiest ◽  
J. Warren Bradley ◽  
Beth A. Lesher ◽  
David M. Habib

2021 ◽  
Author(s):  
Thomas Poulard ◽  
Damien Bachasson ◽  
Quentin Fossé ◽  
Marie-Cécile Niérat ◽  
Jean-Yves Hogrel ◽  
...  

Background The relationship between the diaphragm thickening fraction and the transdiaphragmatic pressure, the reference method to evaluate the diaphragm function, has not been clearly established. This study investigated the global and intraindividual relationship between the thickening fraction of the diaphragm and the transdiaphragmatic pressure. The authors hypothesized that the diaphragm thickening fraction would be positively and significantly correlated to the transdiaphragmatic pressure, in both healthy participants and ventilated patients. Methods Fourteen healthy individuals and 25 mechanically ventilated patients (enrolled in two previous physiologic investigations) participated in the current study. The zone of apposition of the right hemidiaphragm was imaged simultaneously to transdiaphragmatic pressure recording within different breathing conditions, i.e., external inspiratory threshold loading in healthy individuals and various pressure support settings in patients. A blinded offline breath-by-breath analysis synchronously computed the changes in transdiaphragmatic pressure, the diaphragm pressure-time product, and diaphragm thickening fraction. Global and intraindividual relationships between variables were assessed. Results In healthy subjects, both changes in transdiaphragmatic pressure and diaphragm pressure-time product were moderately correlated to diaphragm thickening fraction (repeated measures correlation = 0.40, P < 0.0001; and repeated measures correlation = 0.38, P < 0.0001, respectively). In mechanically ventilated patients, changes in transdiaphragmatic pressure and thickening fraction were weakly correlated (repeated measures correlation = 0.11, P = 0.008), while diaphragm pressure-time product and thickening fraction were not (repeated measures correlation = 0.04, P = 0.396). Individually, changes in transdiaphragmatic pressure and thickening fraction were significantly correlated in 8 of 14 healthy subjects (ρ = 0.30 to 0.85, all P < 0.05) and in 2 of 25 mechanically ventilated patients (ρ = 0.47 to 0.64, all P < 0.05). Diaphragm pressure-time product and thickening fraction correlated in 8 of 14 healthy subjects (ρ = 0.41 to 0.82, all P < 0.02) and in 2 of 25 mechanically ventilated patients (ρ = 0.63 to 0.66, all P < 0.01). Conclusions Overall, diaphragm function as assessed with transdiaphragmatic pressure was weakly related to diaphragm thickening fraction. The diaphragm thickening fraction should not be used in healthy subjects or ventilated patients when changes in diaphragm function are evaluated. Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New


Sign in / Sign up

Export Citation Format

Share Document